The new GLP-1 weight-loss pill vs. the shot: a doctor’s answer on oral Wegovy
FDA approved the Wegovy pill, the first oral semaglutide for weight management, in late December 2025, and it…
The hidden cost of Kiwis not taking their meds
ZOOM Pharmacy’s Din Redzepagic on why nearly a third of New Zealanders don’t take their meds — and…
Mum-of-three and Reiki healer to take over historic Sir John Falstaff pub in Higham
A mum with healing hands is set to become the boss of a historic village pub – and…
Peptide user tore oesophagus after using counterfeit product, Australian regulator warns | Health
A patient who tore their oesophagus after taking a counterfeit version of an experimental weight loss drug has…
Weight-loss drugs v AI: Which one will reshape the economy first – Liam Dann
I don’t doubt it will, but there is uncertainty about the timing. Meanwhile, there’s been plenty of talk…
Patient suffers torn oesophagus after using unapproved peptide, prompting fresh warnings
A patient who used an unapproved peptide labelled as the weight-loss drug retatrutide has suffered a potentially fatal…
Weight loss jabs linked to permanent brain damage – The Daily Telegraph
Weight loss jabs linked to permanent brain damage The Daily TelegraphWeight regain after diet pill use linked to rise…
Weight-loss drugs shaping up to be a boon for grocers’ pharmacy units
While discount stores have been a bright spot recently for major grocery chains, other units within their empires…
AI uncovers hidden Ozempic side effects across 400,000 Reddit posts
Artificial intelligence is giving researchers a new way to listen to what patients are saying about popular GLP-1…
Canada spends $800M on single cancer drug Keytruda
Four years ago, Bill Lake, a retired engineer and avid beekeeper from Battersea, Ontario, was told he had…
Ozempic and Wegovy may raise hair loss risk in some men
Men who are already genetically predisposed to the most common type of hair loss may face an additional…
Life-changing motor neurone disease drug to become affordable for Australians
A breakthrough treatment for a rare form of motor neurone disease is about to become dramatically cheaper, offering…